18 Aug Dr. Bob Kloner and team will present at American Heart Association Annual Scientific Sessions in November in Anaheim
SEVEN presentations submitted by Dr. Bob Kloner and his team (see list below) have been accepted by the American Heart Association. They will be presented at AHA’s Annual Scientific Sessions in November, 2017 in Anaheim, CA. The abstracts for these presentations will also be published in the journal Circulation. The American Heart Association meeting is considered the most prestigious scientific heart disease meeting in the United States, so this is quite an accomplishment on the part of our cardiovascular researchers..
1.) Shi J, Dai W, Carreno J, Hale SL, Kloner RA. Blood-based biomarkers as early predictors of long term outcomes in an experimental model of hemorrhagic shock. Nov 12, 2017
2.) Dai W, Carreno J, Shi J, Hale S, Kloner RA Characterization of myocardial infarct and no-reflow size in Zucker diabetic fatty rat myocardial ischemia/reperfusion model. Nov 14, 2017
3.) Dai W, Shi J, Hale S, Csete M, Carreno J, Kloner RA. Protective effect of isoflurane in an experimental model of hemorrhagic shock. Nov 13, 2017
4.) Dai W, Shi J, Carreno J, Hale S, Kloner RA. Relationship between survival and duration of hypotension in rat fixed pressure hemorrhagic shock model: the first critical 30 minutes. Nov 13, 2017
5.) Kloner RA, Gross C, Yuan J, Conrad A, Pergola PE. Effect of patiromer in hyperkalemic patients with or without RAASi. Nov 14, 2017
6.) Razavi M, Pahlevan N. Wave condition number is useful in predicting risk of coronary heart disease from Framingham Heart Disease Study Data. Nov 13, 2017
7.) In addition Dr. Kloner will serve as a Poster Professor in the session : Novel insights into cardiac cell death on Nov 13, 2017.
Please join us in congratulating Dr. Kloner and his colleagues in the Cardiovascular Institute on this significant and very visible achievement!